Industry Gets Extra Month For 510(k) Revamp Comments
The US FDA has extended the comment period on proposed changes to the 510(k) process until May 22, giving stakeholders an extra 30 days. The controversial proposal would publicize devices that used older predicates.
You may also be interested in...
Despite pushback from industry, US FDA has moved forward with plans to establish a new alternative 510(k) pathway by finalizing a guidance document that describes the so-called “Safety and Performance Based Pathway” that emphasizes use of consensus standards instead of direct predicate comparisons.
A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.
The guidance document explains the history of and requirements for electronic submissions of 510(k)s.